It was in 1996 that Intas Pharmaceuticals Ltd first attracted a private equity investor. Twenty-one years later, PE firms’ interest in the drugmaker hasn’t dampened much.
Your email address will not be published. Required fields are marked *
Notify me of follow-up comments by email.
Notify me of new posts by email.